Kauvery Hospital, Alwarpet, has successfully treated two failing heart valves in a patient without repeat open-heart surgery, ...
Kauvery Hospital, Alwarpet, has successfully treated two failing heart valves in a patient without repeat open-heart surgery, ...
SAN FRANCISCO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced seven-year data from the PARTNER 3 trial, reaffirming the early and sustained patient benefits of Edwards TAVR. The data ...
In mostly women with small aortic annuli, self-expanding valves maintained superior hemodynamics and far lower valve ...
Abstract: To ensure the reasonable and safe electrical layout for converter stations, appropriate air clearance must be determined. At high altitudes, air clearance design has a significant impact.
NEW YORK--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which ...
Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's ...
The Sapien 3 transcatheter heart valve (Image from Edwards Lifesciences) Edwards Lifesciences (NYSE:EW) today presented new data at New York Valves 2026 supporting its transcatheter aortic valve ...
Edwards Lifesciences is entering New York Valves 2026 armed with strong data on its transcatheter aortic valve replacement platforms. The Irvine, CA-based company presented data spanning aortic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results